The Healthcare Financial Management Association (HFMA) Annual Conference 2026, held in June in National Harbor, Maryland, brought together healthcare finance leaders from across the country to discuss the challenges and opportunities shaping the future of healthcare. While there were many valuable sessions, a few themes stood out to me as particularly relevant for healthcare finance professionals as we continue navigating an increasingly complex environment.
Economic & Demographic Pressures Continue to Mount
One of the conference’s most thought-provoking sessions was a keynote presentation delivered by economist and futurist, Andrew Busch. Busch provided a comprehensive look at the economic, demographic, and technological forces influencing healthcare organizations over the coming decade. Busch emphasized that healthcare organizations are operating in an increasingly complex environment shaped by inflation, labor shortages, fiscal challenges, and changing population dynamics. He noted that healthcare is continuing its evolution away from traditional volume-based reimbursement models toward systems that prioritize productivity, outcomes, and affordability.
He also highlighted broader fiscal concerns, including the long-term sustainability of Social Security and Medicare, as well as demographic trends that could significantly impact healthcare demand and workforce availability. The retirement of the Baby Boomer generation, declining birth rates, and changing immigration patterns all have implications for the healthcare industry. As finance professionals, understanding these trends is critical when organizations evaluate future growth strategies and operational needs.
Busch further discussed migration patterns across the United States, noting continued population growth in southern states, such as Texas and North Carolina. These shifts will likely create opportunities for healthcare expansion in some markets while organizations in slower-growth regions may face increasing competition for patients and staff.
Artificial Intelligence Moves from Concept to Strategy
Artificial intelligence was quite the buzz throughout the entire conference. There was a lot of discussion around the growing investments being made by technology companies and governments to expand AI infrastructure and capabilities in healthcare. The reality is that AI is no longer a future consideration but a present-day business strategy that healthcare organizations should be investing in.
Healthcare finance leaders were encouraged to think beyond isolated AI applications and instead develop enterprise-wide strategies that involve collaboration among finance, operations, clinical leadership, and technology teams. Organizations that successfully leverage AI to improve efficiency, decision-making, and patient outcomes will be better positioned to navigate future financial pressures. There are so many ways that AI can help hospitals – automating administrative tasks, managing denials in the revenue cycle, drafting clinical notes to reduce provider burnout, and recognizing trends in patients to proactively identify health issues. These are just a few examples; the potential for AI in healthcare is truly just the tip of the iceberg.
Ongoing Regulatory Concerns: The 340B Rebate Model
One of the sessions I found most informative was about the concerns surrounding the proposed340B Rebate Model Pilot II. The proposed model would represent a significant change from the traditional 340B program structure. Rather than receiving discounted pricing at the point of purchase, hospitals and clinics would purchase drugs at wholesale acquisition cost and subsequently seek reimbursement through a rebate process.
Healthcare leaders expressed concern regarding the potential financial and operational impacts of this approach, especially for organizations already operating on low margins. The model could create cash flow challenges by requiring organizations to fund drug purchases upfront while awaiting rebate payments. The presenters likened this to an “interest-free loan” to the drug manufacturers. There is also expected to be a significant administrative burden associated with managing rebate claims, tracking payments, training staff, and implementing supporting technology systems, all of which will be costly to healthcare organizations.
Also, because many healthcare organizations rely on 340B savings to support uncompensated care, pharmacy assistance programs, behavioral health services, and other community initiatives, uncertainty surrounding the future of the program remains a significant concern throughout the entire industry.
Since the conference concluded, federal regulators have continued moving forward with efforts to implement a revised 340B rebate model. In July, HRSA advanced an Information Collection Request outlining how the revised rebate model could function. Industry groups, including the American Hospital Association (AHA), have continued to express strong concerns as they estimate the model could impose more than $1 billion in annual costs on participating hospitals.
At this point, many operational details remain unresolved, including rebate timing, dispute-resolution procedures, treatment of contract pharmacies, and data-submission requirements. However, based on current discussions, many industry observers believe the most likely implementation date would be January 1, 2027, though an earlier effective date has not been ruled out.
Looking Ahead
The HFMA Annual Conference 2026 reinforced that healthcare organizations must continue adapting to rapid change. Economic pressures, demographic shifts, technological advancements, and evolving regulatory requirements are reshaping the healthcare landscape fast.
Despite these challenges, the overarching message from the conference was that innovation, collaboration, and strategic planning can position healthcare organizations not only to withstand disruption but to succeed in it. Healthcare leaders should increasingly be focusing on embracing technology, strengthening resilience, and finding new ways to deliver high-quality, affordable care in an evolving environment.
The conference served as a reminder that while the future of healthcare may be uncertain, organizations must remain agile and forward-looking in order to be best equipped to meet the challenges ahead.
If you have any questions or are interested in learning more, we are here to help. Please do not hesitate to reach out to discuss your specific situation.
This material has been prepared for general, informational purposes only and is not intended to provide, and should not be relied on for, tax, legal or accounting advice. Should you require any such advice, please contact us directly. The information contained herein does not create, and your review or use of the information does not constitute, an accountant-client relationship.
